Low-dose aspirin use was linked to a 55% lower risk of colorectal cancer recurrence in people with a genetic mutation that ...

Oliver Bathe walks through addressing the surge in papillary thyroid cancer incidence by refining cancer care through ...

Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have ...

A research team has developed an approach to significantly reduce the risk of cancer recurrence and metastasis after surgery, ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

This is the finding of researchers from the National University of Singapore (NUS Medicine) and the Chinese Academy of Sciences (CAS), who have developed the vaccine called NICER to help stop tumor ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

For patients with high-risk HER2-positive early breast cancer who have undergone neoadjuvant therapy, treatment with Enhertu ...

Former nurse at Northwest Hospital (now part of UW Medicine) and its proton therapy facility, Gayle, had multiple treatments ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...